We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
-2.2%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$78.1B
AUM Growth
-$1.98B
(-2.5%)
Cap. Flow
-$7.02B
Cap. Flow
% of AUM
-8.99%
Top 10 Holdings %
Top 10 Hldgs %
28.7%
Holding
1,440
New
63
Increased
853
Reduced
452
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kinross Gold
KGC
|
+$440M |
| 2 |
C.H. Robinson
CHRW
|
+$323M |
| 3 |
Advanced Micro Devices
AMD
|
+$322M |
| 4 |
Tyler Technologies
TYL
|
+$317M |
| 5 |
Merck
MRK
|
+$286M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$11.9B |
| 2 |
NVIDIA
NVDA
|
+$409M |
| 3 |
Autodesk
ADSK
|
+$261M |
| 4 |
Salesforce
CRM
|
+$258M |
| 5 |
Clorox
CLX
|
+$238M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.82% |
| 2 | Materials | 22.17% |
| 3 | Healthcare | 8.64% |
| 4 | Industrials | 7.37% |
| 5 | Financials | 5.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Microchip Technology
MCHP
$41.1B
| $636M | 0.81% |
11,093,007
+3,131,807
| +39% | +$215M |
|
27
Teradyne
TER
$50.3B
| $621M | 0.79% |
4,928,143
+1,846,079
| +60% | +$218M |
|
28
Gold Fields
GFI
$29.2B
| $592M | 0.76% |
44,814,173
-3,691,738
| -8% | -$56.2M |
|
29
AngloGold Ashanti
AU
$39.9B
| $587M | 0.75% |
25,411,814
+2,491,130
| +11% | +$65.1M |
|
30
Gilead Sciences
GILD
$167B
| $566M | 0.72% |
6,123,269
-219,562
| -3% | -$19.8M |
|
31
Pfizer
PFE
$144B
| $565M | 0.72% |
21,286,805
+4,726,549
| +29% | +$128M |
|
32
Corteva
CTVA
$59.5B
| $537M | 0.69% |
9,428,206
+525,531
| +6% | +$31.1M |
|
33
Harmony Gold Mining
HMY
$9.7B
| $516M | 0.66% |
62,889,782
-6,005,306
| -9% | -$58.3M |
|
34
Bristol-Myers Squibb
BMY
$130B
| $513M | 0.66% |
9,069,826
-863,765
| -9% | -$48.3M |
|
35
US Bancorp
USB
$100B
| $487M | 0.62% |
10,183,593
+331,580
| +3% | +$16.3M |
|
36
International Flavors & Fragrances
IFF
$20.2B
| $479M | 0.61% |
5,664,250
+1,663,629
| +42% | +$156M |
|
37
TransUnion
TRU
$16.1B
| $476M | 0.61% |
5,139,607
+356,306
| +7% | +$36.1M |
|
38
Walt Disney
DIS
$172B
| $461M | 0.59% |
4,135,613
-172,181
| -4% | -$18.1M |
|
39
Monolithic Power Systems
MPWR
$63B
| $459M | 0.59% |
776,026
+328,203
| +73% | +$238M |
|
40
MarketAxess Holdings
MKTX
$4.33B
| $452M | 0.58% |
2,000,736
+236,497
| +13% | +$62.3M |
|
41
Allegion
ALLE
$13.7B
| $449M | 0.57% |
3,436,127
+257,175
| +8% | +$36.4M |
|
42
Veeva Systems
VEEV
$32.7B
| $448M | 0.57% |
2,130,498
+135,492
| +7% | +$29.8M |
|
43
Royal Gold
RGLD
$16.6B
| $447M | 0.57% |
3,387,000
-250,739
| -7% | -$36.2M |
|
44
Agilent Technologies
A
$39.7B
| $435M | 0.56% |
3,235,263
+258,358
| +9% | +$35.4M |
|
45
Boeing
BA
$175B
| $431M | 0.55% |
2,434,500
+156,952
| +7% | +$24.6M |
|
46
Kenvue
KVUE
$37.9B
| $428M | 0.55% |
20,069,238
+518,988
| +3% | +$11.8M |
|
47
Microsoft
MSFT
$2.92T
| $428M | 0.55% |
1,015,295
+26,233
| +3% | +$11.2M |
|
48
Zimmer Biomet
ZBH
$18.5B
| $418M | 0.53% |
3,955,449
+218,688
| +6% | +$23.5M |
|
49
Nike
NKE
$63.8B
| $416M | 0.53% |
5,503,841
+618,169
| +13% | +$48.6M |
|
50
Equifax
EFX
$22B
| $412M | 0.53% |
1,617,574
+791,730
| +96% | +$212M |
|
Similar funds
DAM
VanEck Associates's Q4 2024 Portfolio in Review
As of Q4 2024, VanEck Associates held 1,440 positions worth $78.1B, down 2.5% from $80.1B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
VanEck Associates withdrew a net $7.02B in Q4 2024, closing 54 positions and reducing 452 holdings. Its most notable exit was Bank of New York Mellon, an estimated $9.49M position sold in full.
By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 41% a quarter earlier, followed by Materials and Healthcare.
Against the trend, VanEck Associates opened a new position in Boeing Co 6.00% Series A Preferred Stock worth $251M.
- VanEck Associates's largest Q4 2024 buy was Boeing Co 6.00% Series A Preferred Stock: 4,123,397 shares worth $251M.
- VanEck Associates added most to Kinross Gold in Q4 2024, an estimated $440M increase.
- VanEck Associates's biggest Q4 2024 reduction was Lam Research, cutting an estimated $11.9B.
- VanEck Associates fully exited Bank of New York Mellon in Q4 2024, selling an estimated $9.49M.
- VanEck Associates's ten largest holdings make up 29% of its $78.1B portfolio in Q4 2024.
- VanEck Associates opened 63 new positions and closed 54 in Q4 2024.
- VanEck Associates's portfolio value fell 2.5% quarter-over-quarter to $78.1B.
Based on VanEck Associates's 13F filing for Q4 2024, filed 29 Jan 2025.